Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients

NCT00761137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Sialorrhea Secondary to Parkinson's Disease

Interventions

DRUG: 0.3 mg tropicamide
DRUG: 1 mg tropicamide
DRUG: 3 mg tropicamide
DRUG: 0 mg tropicamide

Sponsor

NeuroHealing Pharmaceuticals Inc.

Collaborators

[object Object]